NINGBO INNO PHARMCHEM CO.,LTD. is a key player in supplying specialized chemical compounds that are fundamental to advancements in the pharmaceutical industry. Bufa-20,22-dienolide, 16-(acetyloxy)-14,15-epoxy-3,5-dihydroxy-, (3b,5b,15b,16b)-, identified by CAS number 1108-68-5, is a prime example of such a critical compound. Its molecular formula C26H34O7 underscores its complex structure, making it highly valuable as a pharmaceutical intermediate.

The synthesis of modern pharmaceuticals often involves multi-step processes, where compounds like Bufa-20,22-dienolide act as essential building blocks. The high purity of this chemical, typically above 99%, ensures that subsequent reactions proceed with minimal interference, leading to the development of safe and effective drug products. NINGBO INNO PHARMCHEM CO.,LTD. understands the stringent requirements of the pharmaceutical sector and is committed to delivering intermediates that meet these exacting standards.

For pharmaceutical companies and research institutions, the reliable purchase of Bufa-20,22-dienolide is paramount for maintaining research timelines and production schedules. NINGBO INNO PHARMCHEM CO.,LTD. provides efficient sourcing solutions, connecting clients with reputable fine chemical suppliers. Our expertise in chemical sourcing ensures that clients can obtain the necessary quantities of this compound at competitive prices, supporting their API development initiatives.

The chemical landscape is rich with compounds that have multiple designations; for instance, Bufa-20,22-dienolide is also known by synonyms such as Cinobufotalin. This broad understanding of chemical nomenclature aids researchers in their literature searches and procurement processes. As a distinguished supplier, NINGBO INNO PHARMCHEM CO.,LTD. ensures that all product information is accurate and comprehensive.

In conclusion, the availability of high-quality Bufa-20,22-dienolide (CAS 1108-68-5) is indispensable for the pharmaceutical intermediates sector. NINGBO INNO PHARMCHEM CO.,LTD. remains dedicated to facilitating scientific progress by providing reliable access to this vital fine chemical, thereby contributing to the development of next-generation medicines.